The global Peptic Ulcer Drugs market was valued at US$ 19460 million in 2025 and is anticipated to reach US$ 25170 million by 2032, at a CAGR of 3.8% from 2026 to 2032.

Peptic Ulcer Drugs Market

Peptic ulcer drugs are medications specifically designed to treat and manage peptic ulcers, which are sores that develop on the lining of the stomach, small intestine, or esophagus due to the erosion caused by stomach acid. These drugs work by reducing stomach acid production, protecting the stomach lining, or eradicating the bacteria Helicobacter pylori, which is commonly associated with ulcer formation. The main classes of peptic ulcer drugs include proton pump inhibitors (PPIs), such as omeprazole and esomeprazole, which effectively lower acid secretion by inhibiting the proton pumps in the stomach lining. H2-receptor antagonists, like ranitidine and famotidine, also reduce acid production by blocking histamine receptors on acid-producing cells. Additionally, antacids neutralize existing stomach acid to provide immediate relief from ulcer-related symptoms. Other medications, such as sucralfate, create a protective barrier over the ulcer to aid healing, and antibiotics are used in combination therapies to eradicate H. pylori. These drugs play a crucial role in alleviating symptoms, promoting healing, and preventing ulcer recurrence, significantly improving the quality of life for individuals suffering from peptic ulcers.

The main global Peptic Ulcer Drugs players include Takeda Pharmaceutical, AstraZeneca, Pfizer, Teva Pharmaceuticals, EA Pharma, etc. The top five Peptic Ulcer Drugs players account for approximately 43% of the total market. United States is the largest consumer market for Peptic Ulcer Drugs, accounting for about 30%, followed by Europe and China. In terms of type, Proton Pump Inhibitors is the largest segment, with a share over 68%. And in terms of application, the largest application is Hospital and Clinic, followed by Drugstore.

The market for peptic ulcer drugs is evolving rapidly, driven by advancements in treatment options, increasing prevalence of gastrointestinal disorders, and a growing focus on personalized medicine. Proton pump inhibitors (PPIs) continue to dominate the market due to their efficacy in reducing stomach acid production and promoting ulcer healing. However, there is a notable shift towards exploring alternative therapies and combination treatments to address issues such as antibiotic resistance and long-term PPI use side effects. H2-receptor antagonists remain relevant, especially for patients who experience fewer side effects or need cost-effective solutions.

Recent trends highlight a growing interest in novel drug formulations and over-the-counter (OTC) options, as well as an increased emphasis on targeted therapies that address specific causes of ulcers, such as Helicobacter pylori infection. The market is also seeing innovations in drug delivery systems and adjunctive therapies designed to enhance treatment outcomes and patient compliance. Furthermore, rising awareness and diagnostic advancements are contributing to early detection and management of peptic ulcers, further driving market growth.

This report delivers a comprehensive overview of the global Peptic Ulcer Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Peptic Ulcer Drugs. The Peptic Ulcer Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Peptic Ulcer Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Peptic Ulcer Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Peptic Ulcer Drugs Market Report

Report Metric	Details
Report Name	Peptic Ulcer Drugs Market
Accounted market size in 2025	US$ 19460 million
Forecasted market size in 2032	US$ 25170 million
CAGR	3.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Proton Pump Inhibitors H2-Antagonists Antacids Others
Segment by Application	Hospital and Clinic Drugstore
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Livzon Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, CTTQ, Luoxin Pharmaceuticals, Takeda, Eisai, Jumpcan Pharmaceutical, Zhejiang Conba Pharmaceutical, Youcare Pharmaceutical, Chongqing Lummy Pharmaceutical, Huadong Medicine, Hansoh Pharmaceutical, CR Double-Crane, Hunan Warrant Pharmaceutical, Changzhou Siyao Pharmaceuticals, Chongqing Pharscin Pharmaceutical, Lionco Pharmaceutical, Jiangsu Wuzhong Pharmaceutical, Cisen Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Peptic Ulcer Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Peptic Ulcer Drugs Market growing?

Ans: The Peptic Ulcer Drugs Market witnessing a CAGR of 3.8% during the forecast period 2026-2032.

What is the Peptic Ulcer Drugs Market size in 2032?

Ans: The Peptic Ulcer Drugs Market size in 2032 will be US$ 25170 million.

What is the market share of major companies in Peptic Ulcer Drugs Market?

Ans: The top five Peptic Ulcer Drugs players account for approximately 43% of the total market.

What is the Peptic Ulcer Drugs Market share by region?

Ans: United States is the largest consumer market for Peptic Ulcer Drugs, accounting for about 30%, followed by Europe and China.

What is the Peptic Ulcer Drugs Market share by type?

Ans: In terms of type, Proton Pump Inhibitors is the largest segment, with a share over 68%.

Who are the main players in the Peptic Ulcer Drugs Market report?

Ans: The main players in the Peptic Ulcer Drugs Market are AstraZeneca, Livzon Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, CTTQ, Luoxin Pharmaceuticals, Takeda, Eisai, Jumpcan Pharmaceutical, Zhejiang Conba Pharmaceutical, Youcare Pharmaceutical, Chongqing Lummy Pharmaceutical, Huadong Medicine, Hansoh Pharmaceutical, CR Double-Crane, Hunan Warrant Pharmaceutical, Changzhou Siyao Pharmaceuticals, Chongqing Pharscin Pharmaceutical, Lionco Pharmaceutical, Jiangsu Wuzhong Pharmaceutical, Cisen Pharmaceutical

What are the Application segmentation covered in the Peptic Ulcer Drugs Market report?

Ans: The Applications covered in the Peptic Ulcer Drugs Market report are Hospital and Clinic, Drugstore

What are the Type segmentation covered in the Peptic Ulcer Drugs Market report?

Ans: The Types covered in the Peptic Ulcer Drugs Market report are Proton Pump Inhibitors, H2-Antagonists, Antacids, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptic Ulcer Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Proton Pump Inhibitors

1.2.3 H2-Antagonists

1.2.4 Antacids

1.2.5 Others

1.3 Market by Application

1.3.1 Global Peptic Ulcer Drugs Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital and Clinic

1.3.3 Drugstore

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptic Ulcer Drugs Market Perspective (2021–2032)

2.2 Global Peptic Ulcer Drugs Growth Trends by Region

2.2.1 Global Peptic Ulcer Drugs Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Peptic Ulcer Drugs Historic Market Size by Region (2021–2026)

2.2.3 Peptic Ulcer Drugs Forecasted Market Size by Region (2027–2032)

2.3 Peptic Ulcer Drugs Market Dynamics

2.3.1 Peptic Ulcer Drugs Industry Trends

2.3.2 Peptic Ulcer Drugs Market Drivers

2.3.3 Peptic Ulcer Drugs Market Challenges

2.3.4 Peptic Ulcer Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptic Ulcer Drugs Players by Revenue

3.1.1 Global Top Peptic Ulcer Drugs Players by Revenue (2021–2026)

3.1.2 Global Peptic Ulcer Drugs Revenue Market Share by Players (2021–2026)

3.2 Global Top Peptic Ulcer Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Peptic Ulcer Drugs Revenue

3.4 Global Peptic Ulcer Drugs Market Concentration Ratio

3.4.1 Global Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptic Ulcer Drugs Revenue in 2025

3.5 Global Key Players of Peptic Ulcer Drugs Head Offices and Areas Served

3.6 Global Key Players of Peptic Ulcer Drugs, Products and Applications

3.7 Global Key Players of Peptic Ulcer Drugs, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Peptic Ulcer Drugs Breakdown Data by Type

4.1 Global Peptic Ulcer Drugs Historic Market Size by Type (2021–2026)

4.2 Global Peptic Ulcer Drugs Forecasted Market Size by Type (2027–2032)

5 Peptic Ulcer Drugs Breakdown Data by Application

5.1 Global Peptic Ulcer Drugs Historic Market Size by Application (2021–2026)

5.2 Global Peptic Ulcer Drugs Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Peptic Ulcer Drugs Market Size (2021–2032)

6.2 North America Peptic Ulcer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Peptic Ulcer Drugs Market Size by Country (2021–2026)

6.4 North America Peptic Ulcer Drugs Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptic Ulcer Drugs Market Size (2021–2032)

7.2 Europe Peptic Ulcer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Peptic Ulcer Drugs Market Size by Country (2021–2026)

7.4 Europe Peptic Ulcer Drugs Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Peptic Ulcer Drugs Market Size (2021–2032)

8.2 Asia-Pacific Peptic Ulcer Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Peptic Ulcer Drugs Market Size by Region (2021–2026)

8.4 Asia-Pacific Peptic Ulcer Drugs Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Peptic Ulcer Drugs Market Size (2021–2032)

9.2 Latin America Peptic Ulcer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Peptic Ulcer Drugs Market Size by Country (2021–2026)

9.4 Latin America Peptic Ulcer Drugs Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptic Ulcer Drugs Market Size (2021–2032)

10.2 Middle East & Africa Peptic Ulcer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Peptic Ulcer Drugs Market Size by Country (2021–2026)

10.4 Middle East & Africa Peptic Ulcer Drugs Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Peptic Ulcer Drugs Introduction

11.1.4 AstraZeneca Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.1.5 AstraZeneca Recent Development

11.2 Livzon Pharmaceutical

11.2.1 Livzon Pharmaceutical Company Details

11.2.2 Livzon Pharmaceutical Business Overview

11.2.3 Livzon Pharmaceutical Peptic Ulcer Drugs Introduction

11.2.4 Livzon Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.2.5 Livzon Pharmaceutical Recent Development

11.3 Jiangsu Aosaikang Pharmaceutical

11.3.1 Jiangsu Aosaikang Pharmaceutical Company Details

11.3.2 Jiangsu Aosaikang Pharmaceutical Business Overview

11.3.3 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Drugs Introduction

11.3.4 Jiangsu Aosaikang Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.3.5 Jiangsu Aosaikang Pharmaceutical Recent Development

11.4 CTTQ

11.4.1 CTTQ Company Details

11.4.2 CTTQ Business Overview

11.4.3 CTTQ Peptic Ulcer Drugs Introduction

11.4.4 CTTQ Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.4.5 CTTQ Recent Development

11.5 Luoxin Pharmaceuticals

11.5.1 Luoxin Pharmaceuticals Company Details

11.5.2 Luoxin Pharmaceuticals Business Overview

11.5.3 Luoxin Pharmaceuticals Peptic Ulcer Drugs Introduction

11.5.4 Luoxin Pharmaceuticals Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.5.5 Luoxin Pharmaceuticals Recent Development

11.6 Takeda

11.6.1 Takeda Company Details

11.6.2 Takeda Business Overview

11.6.3 Takeda Peptic Ulcer Drugs Introduction

11.6.4 Takeda Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.6.5 Takeda Recent Development

11.7 Eisai

11.7.1 Eisai Company Details

11.7.2 Eisai Business Overview

11.7.3 Eisai Peptic Ulcer Drugs Introduction

11.7.4 Eisai Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.7.5 Eisai Recent Development

11.8 Jumpcan Pharmaceutical

11.8.1 Jumpcan Pharmaceutical Company Details

11.8.2 Jumpcan Pharmaceutical Business Overview

11.8.3 Jumpcan Pharmaceutical Peptic Ulcer Drugs Introduction

11.8.4 Jumpcan Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.8.5 Jumpcan Pharmaceutical Recent Development

11.9 Zhejiang Conba Pharmaceutical

11.9.1 Zhejiang Conba Pharmaceutical Company Details

11.9.2 Zhejiang Conba Pharmaceutical Business Overview

11.9.3 Zhejiang Conba Pharmaceutical Peptic Ulcer Drugs Introduction

11.9.4 Zhejiang Conba Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.9.5 Zhejiang Conba Pharmaceutical Recent Development

11.10 Youcare Pharmaceutical

11.10.1 Youcare Pharmaceutical Company Details

11.10.2 Youcare Pharmaceutical Business Overview

11.10.3 Youcare Pharmaceutical Peptic Ulcer Drugs Introduction

11.10.4 Youcare Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.10.5 Youcare Pharmaceutical Recent Development

11.11 Chongqing Lummy Pharmaceutical

11.11.1 Chongqing Lummy Pharmaceutical Company Details

11.11.2 Chongqing Lummy Pharmaceutical Business Overview

11.11.3 Chongqing Lummy Pharmaceutical Peptic Ulcer Drugs Introduction

11.11.4 Chongqing Lummy Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.11.5 Chongqing Lummy Pharmaceutical Recent Development

11.12 Huadong Medicine

11.12.1 Huadong Medicine Company Details

11.12.2 Huadong Medicine Business Overview

11.12.3 Huadong Medicine Peptic Ulcer Drugs Introduction

11.12.4 Huadong Medicine Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.12.5 Huadong Medicine Recent Development

11.13 Hansoh Pharmaceutical

11.13.1 Hansoh Pharmaceutical Company Details

11.13.2 Hansoh Pharmaceutical Business Overview

11.13.3 Hansoh Pharmaceutical Peptic Ulcer Drugs Introduction

11.13.4 Hansoh Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.13.5 Hansoh Pharmaceutical Recent Development

11.14 CR Double-Crane

11.14.1 CR Double-Crane Company Details

11.14.2 CR Double-Crane Business Overview

11.14.3 CR Double-Crane Peptic Ulcer Drugs Introduction

11.14.4 CR Double-Crane Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.14.5 CR Double-Crane Recent Development

11.15 Hunan Warrant Pharmaceutical

11.15.1 Hunan Warrant Pharmaceutical Company Details

11.15.2 Hunan Warrant Pharmaceutical Business Overview

11.15.3 Hunan Warrant Pharmaceutical Peptic Ulcer Drugs Introduction

11.15.4 Hunan Warrant Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.15.5 Hunan Warrant Pharmaceutical Recent Development

11.16 Changzhou Siyao Pharmaceuticals

11.16.1 Changzhou Siyao Pharmaceuticals Company Details

11.16.2 Changzhou Siyao Pharmaceuticals Business Overview

11.16.3 Changzhou Siyao Pharmaceuticals Peptic Ulcer Drugs Introduction

11.16.4 Changzhou Siyao Pharmaceuticals Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.16.5 Changzhou Siyao Pharmaceuticals Recent Development

11.17 Chongqing Pharscin Pharmaceutical

11.17.1 Chongqing Pharscin Pharmaceutical Company Details

11.17.2 Chongqing Pharscin Pharmaceutical Business Overview

11.17.3 Chongqing Pharscin Pharmaceutical Peptic Ulcer Drugs Introduction

11.17.4 Chongqing Pharscin Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.17.5 Chongqing Pharscin Pharmaceutical Recent Development

11.18 Lionco Pharmaceutical

11.18.1 Lionco Pharmaceutical Company Details

11.18.2 Lionco Pharmaceutical Business Overview

11.18.3 Lionco Pharmaceutical Peptic Ulcer Drugs Introduction

11.18.4 Lionco Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.18.5 Lionco Pharmaceutical Recent Development

11.19 Jiangsu Wuzhong Pharmaceutical

11.19.1 Jiangsu Wuzhong Pharmaceutical Company Details

11.19.2 Jiangsu Wuzhong Pharmaceutical Business Overview

11.19.3 Jiangsu Wuzhong Pharmaceutical Peptic Ulcer Drugs Introduction

11.19.4 Jiangsu Wuzhong Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.19.5 Jiangsu Wuzhong Pharmaceutical Recent Development

11.20 Cisen Pharmaceutical

11.20.1 Cisen Pharmaceutical Company Details

11.20.2 Cisen Pharmaceutical Business Overview

11.20.3 Cisen Pharmaceutical Peptic Ulcer Drugs Introduction

11.20.4 Cisen Pharmaceutical Revenue in Peptic Ulcer Drugs Business (2021–2026)

11.20.5 Cisen Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Livzon Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

CTTQ

Luoxin Pharmaceuticals

Takeda

Eisai Co Ltd

Jumpcan Pharmaceutical

Zhejiang Conba Pharmaceutical

Youcare Pharmaceutical

Chongqing Lummy Pharmaceutical

Huadong Medicine

Hansoh Pharmaceutical

CR Double-Crane

Hunan Warrant Pharmaceutical

Changzhou Siyao Pharmaceuticals

Chongqing Pharscin pharmaceutical

Lionco Pharmaceutical

Jiangsu Wuzhong Pharmaceutical

Cisen Pharmaceutical

List of Tables

Table 1. Global Peptic Ulcer Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Proton Pump Inhibitors

Table 3. Key Players of H2-Antagonists

Table 4. Key Players of Antacids

Table 5. Key Players of Others

Table 6. Global Peptic Ulcer Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Peptic Ulcer Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Peptic Ulcer Drugs Market Size by Region (US$ Million), 2021–2026

Table 9. Global Peptic Ulcer Drugs Market Share by Region (2021–2026)

Table 10. Global Peptic Ulcer Drugs Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Peptic Ulcer Drugs Market Share by Region (2027–2032)

Table 12. Peptic Ulcer Drugs Market Trends

Table 13. Peptic Ulcer Drugs Market Drivers

Table 14. Peptic Ulcer Drugs Market Challenges

Table 15. Peptic Ulcer Drugs Market Restraints

Table 16. Global Peptic Ulcer Drugs Revenue by Players (US$ Million), 2021–2026

Table 17. Global Peptic Ulcer Drugs Market Share by Players (2021–2026)

Table 18. Global Top Peptic Ulcer Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Peptic Ulcer Drugs Revenue, 2025

Table 19. Ranking of Global Top Peptic Ulcer Drugs Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Peptic Ulcer Drugs Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Peptic Ulcer Drugs, Headquarters and Area Served

Table 22. Global Key Players of Peptic Ulcer Drugs, Products and Applications

Table 23. Global Key Players of Peptic Ulcer Drugs, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Peptic Ulcer Drugs Market Size by Type (US$ Million), 2021–2026

Table 26. Global Peptic Ulcer Drugs Revenue Market Share by Type (2021–2026)

Table 27. Global Peptic Ulcer Drugs Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Peptic Ulcer Drugs Revenue Market Share by Type (2027–2032)

Table 29. Global Peptic Ulcer Drugs Market Size by Application (US$ Million), 2021–2026

Table 30. Global Peptic Ulcer Drugs Revenue Market Share by Application (2021–2026)

Table 31. Global Peptic Ulcer Drugs Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Peptic Ulcer Drugs Revenue Market Share by Application (2027–2032)

Table 33. North America Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Peptic Ulcer Drugs Market Size by Country (US$ Million), 2021–2026

Table 35. North America Peptic Ulcer Drugs Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Peptic Ulcer Drugs Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Peptic Ulcer Drugs Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Peptic Ulcer Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Peptic Ulcer Drugs Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Peptic Ulcer Drugs Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Peptic Ulcer Drugs Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Peptic Ulcer Drugs Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Peptic Ulcer Drugs Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Peptic Ulcer Drugs Market Size by Country (US$ Million), 2027–2032

Table 48. AstraZeneca Company Details

Table 49. AstraZeneca Business Overview

Table 50. AstraZeneca Peptic Ulcer Drugs Product

Table 51. AstraZeneca Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 52. AstraZeneca Recent Development

Table 53. Livzon Pharmaceutical Company Details

Table 54. Livzon Pharmaceutical Business Overview

Table 55. Livzon Pharmaceutical Peptic Ulcer Drugs Product

Table 56. Livzon Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 57. Livzon Pharmaceutical Recent Development

Table 58. Jiangsu Aosaikang Pharmaceutical Company Details

Table 59. Jiangsu Aosaikang Pharmaceutical Business Overview

Table 60. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Drugs Product

Table 61. Jiangsu Aosaikang Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 62. Jiangsu Aosaikang Pharmaceutical Recent Development

Table 63. CTTQ Company Details

Table 64. CTTQ Business Overview

Table 65. CTTQ Peptic Ulcer Drugs Product

Table 66. CTTQ Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 67. CTTQ Recent Development

Table 68. Luoxin Pharmaceuticals Company Details

Table 69. Luoxin Pharmaceuticals Business Overview

Table 70. Luoxin Pharmaceuticals Peptic Ulcer Drugs Product

Table 71. Luoxin Pharmaceuticals Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 72. Luoxin Pharmaceuticals Recent Development

Table 73. Takeda Company Details

Table 74. Takeda Business Overview

Table 75. Takeda Peptic Ulcer Drugs Product

Table 76. Takeda Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 77. Takeda Recent Development

Table 78. Eisai Company Details

Table 79. Eisai Business Overview

Table 80. Eisai Peptic Ulcer Drugs Product

Table 81. Eisai Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 82. Eisai Recent Development

Table 83. Jumpcan Pharmaceutical Company Details

Table 84. Jumpcan Pharmaceutical Business Overview

Table 85. Jumpcan Pharmaceutical Peptic Ulcer Drugs Product

Table 86. Jumpcan Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 87. Jumpcan Pharmaceutical Recent Development

Table 88. Zhejiang Conba Pharmaceutical Company Details

Table 89. Zhejiang Conba Pharmaceutical Business Overview

Table 90. Zhejiang Conba Pharmaceutical Peptic Ulcer Drugs Product

Table 91. Zhejiang Conba Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 92. Zhejiang Conba Pharmaceutical Recent Development

Table 93. Youcare Pharmaceutical Company Details

Table 94. Youcare Pharmaceutical Business Overview

Table 95. Youcare Pharmaceutical Peptic Ulcer Drugs Product

Table 96. Youcare Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 97. Youcare Pharmaceutical Recent Development

Table 98. Chongqing Lummy Pharmaceutical Company Details

Table 99. Chongqing Lummy Pharmaceutical Business Overview

Table 100. Chongqing Lummy Pharmaceutical Peptic Ulcer Drugs Product

Table 101. Chongqing Lummy Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 102. Chongqing Lummy Pharmaceutical Recent Development

Table 103. Huadong Medicine Company Details

Table 104. Huadong Medicine Business Overview

Table 105. Huadong Medicine Peptic Ulcer Drugs Product

Table 106. Huadong Medicine Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 107. Huadong Medicine Recent Development

Table 108. Hansoh Pharmaceutical Company Details

Table 109. Hansoh Pharmaceutical Business Overview

Table 110. Hansoh Pharmaceutical Peptic Ulcer Drugs Product

Table 111. Hansoh Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 112. Hansoh Pharmaceutical Recent Development

Table 113. CR Double-Crane Company Details

Table 114. CR Double-Crane Business Overview

Table 115. CR Double-Crane Peptic Ulcer Drugs Product

Table 116. CR Double-Crane Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 117. CR Double-Crane Recent Development

Table 118. Hunan Warrant Pharmaceutical Company Details

Table 119. Hunan Warrant Pharmaceutical Business Overview

Table 120. Hunan Warrant Pharmaceutical Peptic Ulcer Drugs Product

Table 121. Hunan Warrant Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 122. Hunan Warrant Pharmaceutical Recent Development

Table 123. Changzhou Siyao Pharmaceuticals Company Details

Table 124. Changzhou Siyao Pharmaceuticals Business Overview

Table 125. Changzhou Siyao Pharmaceuticals Peptic Ulcer Drugs Product

Table 126. Changzhou Siyao Pharmaceuticals Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 127. Changzhou Siyao Pharmaceuticals Recent Development

Table 128. Chongqing Pharscin Pharmaceutical Company Details

Table 129. Chongqing Pharscin Pharmaceutical Business Overview

Table 130. Chongqing Pharscin Pharmaceutical Peptic Ulcer Drugs Product

Table 131. Chongqing Pharscin Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 132. Chongqing Pharscin Pharmaceutical Recent Development

Table 133. Lionco Pharmaceutical Company Details

Table 134. Lionco Pharmaceutical Business Overview

Table 135. Lionco Pharmaceutical Peptic Ulcer Drugs Product

Table 136. Lionco Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 137. Lionco Pharmaceutical Recent Development

Table 138. Jiangsu Wuzhong Pharmaceutical Company Details

Table 139. Jiangsu Wuzhong Pharmaceutical Business Overview

Table 140. Jiangsu Wuzhong Pharmaceutical Peptic Ulcer Drugs Product

Table 141. Jiangsu Wuzhong Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 142. Jiangsu Wuzhong Pharmaceutical Recent Development

Table 143. Cisen Pharmaceutical Company Details

Table 144. Cisen Pharmaceutical Business Overview

Table 145. Cisen Pharmaceutical Peptic Ulcer Drugs Product

Table 146. Cisen Pharmaceutical Revenue in Peptic Ulcer Drugs Business (US$ Million), 2021–2026

Table 147. Cisen Pharmaceutical Recent Development

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Peptic Ulcer Drugs Picture

Figure 2. Global Peptic Ulcer Drugs Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Peptic Ulcer Drugs Market Share by Type: 2025 vs 2032

Figure 4. Proton Pump Inhibitors Features

Figure 5. H2-Antagonists Features

Figure 6. Antacids Features

Figure 7. Others Features

Figure 8. Global Peptic Ulcer Drugs Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Peptic Ulcer Drugs Market Share by Application: 2025 vs 2032

Figure 10. Hospital and Clinic Case Studies

Figure 11. Drugstore Case Studies

Figure 12. Peptic Ulcer Drugs Report Years Considered

Figure 13. Global Peptic Ulcer Drugs Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Peptic Ulcer Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Peptic Ulcer Drugs Market Share by Region: 2025 vs 2032

Figure 16. Global Peptic Ulcer Drugs Market Share by Players in 2025

Figure 17. Global Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Peptic Ulcer Drugs Revenue in 2025

Figure 19. North America Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Peptic Ulcer Drugs Market Share by Country (2021–2032)

Figure 21. United States Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Peptic Ulcer Drugs Market Share by Country (2021–2032)

Figure 25. Germany Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Peptic Ulcer Drugs Market Share by Region (2021–2032)

Figure 33. China Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Peptic Ulcer Drugs Market Share by Country (2021–2032)

Figure 41. Mexico Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Peptic Ulcer Drugs Market Share by Country (2021–2032)

Figure 45. Israel Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. AstraZeneca Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 49. Livzon Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 50. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 51. CTTQ Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 52. Luoxin Pharmaceuticals Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 53. Takeda Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 54. Eisai Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 55. Jumpcan Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 56. Zhejiang Conba Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 57. Youcare Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 58. Chongqing Lummy Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 59. Huadong Medicine Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 60. Hansoh Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 61. CR Double-Crane Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 62. Hunan Warrant Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 63. Changzhou Siyao Pharmaceuticals Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 64. Chongqing Pharscin Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 65. Lionco Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 66. Jiangsu Wuzhong Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 67. Cisen Pharmaceutical Revenue Growth Rate in Peptic Ulcer Drugs Business (2021–2026)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Peptic Ulcer Disease Medication Market Research Report 2025

Global Anti Peptic Ulcer Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Proton Pump Inhibitors Market

Global Proton Pump Inhibitors PPIs Market Research Report 2024

Global Proton Pump Inhibitors for Gastric Acid Therapy Market Research Report 2025

Global Gastric Mucosal Protective Drugs Market Research Report 2024

Global Oral Proton Pump Inhibitors PPIs Market Research Report 2024

Global Drugs That Neutralize Stomach Acid Market Research Report 2024

Global Stomach Medicine Market Research Report 2024

Global Prescription Proton Pump Inhibitor Market Research Report 2024

Global Peptic Ulcer Treatment Drugs Market Research Report 2024

Global PPI Acid Suppressant Market Research Report 2024

Global Pantoprazole Market Research Report 2024

Global Ranitidine Hydrochloride Capsules Market Research Report 2024

Global Acid Reducer Market Research Report 2025

Global Antiulcerant Drugs Market Insights Forecast to 2030

Histamine H2 receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

H2 Antagonists or H2 blockers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Peptic Ulcer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions